Covis Enters Promotion and Distribution Agreement for Two Respiratory Medicines, Seebri® Breezhaler® and Ultibro® Breezhaler®, in Canada

NEXT STORY
Worldwide Vaccine Vial Monitor Industry to 2026 – Abrupt Rise in COVID-19 Infection Across Geographies Presents Opportunities
PREV STORY
Immunicum Transfers Patent Rights for Modified Adenovirus to Elicera Therapeutics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results

CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its ...

author_avatar
NASDAQ Market News

Publishing of Orion Corporation’s Interim Report for January-March 2016 on 27 April 2016

ORION CORPORATION     STOCK EXCHANGE RELEASE   13 APRIL 2016 at 10:30 A.M. EEST Publishing of ...

author_avatar
NASDAQ Market News

Retia Medical Establishes World-Class Clinical Advisory Board to Support Critical Advances in Hemodynamic Monitoring

-The Retia Argos Cardiac Output Monitor, which provides superior accuracy for hemodynamic monitoring, will ...

author_avatar
NASDAQ Market News